Table 1.
Immunological evaluation of the patient
| Parameters | Patient | Reference values |
|---|---|---|
| Absolute lymphocyte/mm3 | 1,200 | 2,600–10,400 |
| Immunoglobulins, mg/dL | ||
| IgG | 601 | 764–2,134 |
| IgM | 22 | 69–387 |
| IgA | 6.6 | 78–383 |
| IgE, IU/L | 9.8 | 2–97 |
| Immunophenotyping | ||
| CD3+ cells %, (n) | 54 (648) | 55–88 (1,213–4,128) |
| CD3+CD4+ %, (n) | 26 (312) | 24–50 (647–1,111) |
| CD3+CD8+ %, (n) | 19 (228) | 17.5–42 (379–2083) |
| CD4+/CD8+ ratio | 1.3 | 1.3–3.9 |
| CD3+CD4+CD45RA+, % | 1 | 41–81 |
| CD3+CD4+CD45RO+, % | 99 | 26–58 |
| CD3+CD8+CD45RA+, % | 24 | 39–93 |
| CD3+CD8+CD45RO+, % | 77 | 11–79 |
| CD19+ cells %, (n) | 5.4 (64) | 7.4–22 (197–867) |
| Naïve CD19+CD27−IgD+, % | 51 | 5.5–90 |
| Memory unswitched CD19+CD27+IgD+, % | 27 | 5.9–28 |
| Memory switched CD19+CD27−IgD−, % | 11 | 6.7–31 |
| CD16+/CD56+ cells, % | 33 | 4–29 |